膵管ステント・胆道ステントの世界市場 - 市場規模（セグメント別）、シェア、規制、償還、処置、予測（～2033年）

膵管ステント・胆道ステント市場は主に、胆管や膵管の閉塞をもたらす疾患によって牽引されています。ERCPおよびPTCの施術数の増加が、特にステント留置および反復ステント留置を必要とする処置の市場を活性化させています。

当レポートでは、世界の膵管ステント・胆道ステント市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの膵管ステント・胆道ステントと進化する競合情勢

• 主な業界動向の考察
• 膵管ステント・胆道ステント市場のセグメント別の年間収益と市場見通し（2015年～2033年）
• セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 膵管ステント・胆道ステント市場のSWOT分析
• 膵管ステント・胆道ステント市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Boston Scientific Corp
• Becton Dickinson and Co
• Hellman & Friedman LLC
• ConMed Corp
• Cook Group Inc
• Hobbs Medical Inc
• Medtronic Plc
• Olympus Corp
• W. L. Gore & Associates Inc
• その他

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Pancreatic and Biliary stent Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Pancreatic and Biliary Stents market for the year 2020 and beyond. Pancreatic and Biliary Stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

The Pancreatic and Biliary Stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fuelled the market especially the procedures requiring stenting and recurrent stenting.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Pancreatic and Biliary Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Pancreatic and Biliary Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Pancreatic and Biliary stent market.
• Competitive dynamics insights and trends provided for Pancreatic and Biliary stent market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, Hellman & Friedman LLC, ConMed Corp, Cook Group Inc, Hobbs Medical Inc, Medtronic Plc, Olympus Corp, W. L. Gore & Associates Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

CMO executives who must have deep understanding of the Pancreatic and Biliary Stents marketplace to make strategic planning and investment decisions.

Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

Understand the impact of COVID-19 on Pancreatic and Biliary Stents market.

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving Pancreatic and Biliary Stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pancreatic and Biliary Stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific Pancreatic and Biliary Stents market from 2015-2033.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable